Loading organizations...
Loading organizations...
Pharmaceuticals for diseases caused by oxidative stress and tissue damage.
Transcend Therapeutics has raised $40.0M across 1 funding round.
Transcend Therapeutics has raised $40.0M in total across 1 funding round.
Transcend Therapeutics has raised $40.0M in total across 1 funding round.
Transcend Therapeutics's investors include Rick Gerson, Falcon Edge Capital, Integrated, Kevin Ryan, Emerald Investment Managers, Global Founders Capital.
Transcend Therapeutics has raised $40.0M across 1 funding round. Most recently, it raised $40.0M Series A in February 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 23, 2023 | $40.0M Series A | Rick Gerson, Falcon Edge Capital, Integrated | Kevin Ryan, Emerald Investment Managers, Global Founders Capital |